Related Experiment Video
Updated: Mar 22, 2026

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
43.2K
The pre-metastatic niche: is metastasis random?
Thomas R Cox1, Alison Gartland2, Janine T Erler1
1Biotech Research and Innovation Centre, University of Copenhagen , Copenhagen, Denmark .
Bonekey Reports
|April 30, 2016
Summary
Solid tumors spread through a complex process involving tumor and host cells. Understanding how tumors create pre-metastatic niches is key to developing new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Cellular and Molecular Medicine
Background:
- Tumor metastasis is a complex, systemic process involving primary tumor cells and host cells.
- Tumor cell recruitment and activation of host cells are critical for metastatic dissemination.
- The concept of pre-metastatic niches is gaining interest, complementing the 'seed and soil' hypothesis.
Purpose of the Study:
- To explore the intricate mechanisms by which primary tumors establish distant metastatic sites.
- To understand how tumor cells alter the microenvironment at future metastatic locations.
- To identify novel therapeutic strategies targeting the pre-metastatic niche formation process.
Main Methods:
- This study involves a comprehensive review and analysis of current research on tumor metastasis and pre-metastatic niche formation.
- Key molecular and cellular interactions between tumor cells and host cells are examined.
- The role of the tumor microenvironment in facilitating metastasis is investigated.
Main Results:
- Primary tumors actively recruit and educate host cells to create a supportive microenvironment at distant sites.
- The formation of pre-metastatic niches involves complex crosstalk between tumor-derived factors and stromal cells.
- These niches facilitate the survival, growth, and vascularization of disseminated tumor cells.
Conclusions:
- Tumor metastasis is a highly orchestrated, systemic event driven by the tumor's ability to manipulate host environments.
- Targeting the pre-metastatic niche offers a promising avenue for novel anti-metastatic therapies.
- Further research into the dynamic networks of metastasis is crucial for advancing cancer treatment.
Related Concept Videos
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis
3.8K
3.8K
Stem Cell Niche
6.5K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.5K
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K

